Target type: biologicalprocess
Any process that modulates the frequency, rate, or extent of an acute inflammatory response. [GOC:add]
The acute inflammatory response is a complex and tightly regulated process that serves to protect the body from injury and infection. It is characterized by a rapid influx of immune cells, fluid, and mediators to the site of injury or infection. This process involves a cascade of events, including:
1. **Recognition of pathogens and damaged tissues:** Pattern recognition receptors (PRRs) on immune cells recognize pathogen-associated molecular patterns (PAMPs) from invading pathogens and damage-associated molecular patterns (DAMPs) released from injured tissues.
2. **Activation of immune cells:** PRR activation triggers the release of pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6, by immune cells, mainly macrophages and neutrophils. These cytokines activate other immune cells, including T cells and B cells, and promote the expression of adhesion molecules on endothelial cells.
3. **Recruitment of immune cells:** Adhesion molecules facilitate the migration of leukocytes from the bloodstream to the site of inflammation. This process, known as leukocyte extravasation, involves a series of steps, including rolling, activation, firm adhesion, and transmigration.
4. **Inflammation resolution:** Once the infection or injury is resolved, the inflammatory response must be terminated to prevent tissue damage. This process involves the production of anti-inflammatory cytokines, such as IL-10 and TGF-β, which suppress the pro-inflammatory response.
5. **Tissue repair:** The resolution phase involves the removal of debris, the formation of new blood vessels, and the restoration of tissue function.
The regulation of the acute inflammatory response is essential for maintaining tissue homeostasis and preventing excessive inflammation. Dysregulation of this process can lead to chronic inflammation and the development of various diseases, including autoimmune diseases, atherosclerosis, and cancer.
The regulation of the acute inflammatory response is influenced by a variety of factors, including:
* **Genetic factors:** Individual differences in gene expression and function can influence the susceptibility to inflammation and the severity of the inflammatory response.
* **Environmental factors:** Exposure to environmental toxins, allergens, and pathogens can trigger inflammation.
* **Lifestyle factors:** Diet, exercise, and stress can also influence the inflammatory response.
Understanding the intricate mechanisms that regulate the acute inflammatory response is crucial for developing targeted therapies for inflammatory diseases.'
```"
Protein | Definition | Taxonomy |
---|---|---|
Deoxyribonuclease-1 | A deoxyribonuclease-1 that is encoded in the genome of cow. [OMA:P00639, PRO:DNx] | Bos taurus (cattle) |
Deoxyribonuclease-1 | A deoxyribonuclease-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P24855] | Homo sapiens (human) |
Free fatty acid receptor 2 | A free fatty acid receptor 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:O15552] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
acetic acid | acetic acid : A simple monocarboxylic acid containing two carbons. Acetic Acid: Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed) | monocarboxylic acid | antimicrobial food preservative; Daphnia magna metabolite; food acidity regulator; protic solvent |
propionic acid | propionic acid : A short-chain saturated fatty acid comprising ethane attached to the carbon of a carboxy group. | saturated fatty acid; short-chain fatty acid | antifungal drug |
gentian violet | crystal violet cation : An iminium ion that is malachite green cation in which the hydrogen at the para- psition of the monosubstituted phenyl group is replaced by a dimethylamino group. | iminium ion | antibacterial agent; antifungal agent |
camptothecin | NSC 100880: carboxylate (opened lactone) form of camptothecin; RN refers to (S)-isomer; structure given in first source | delta-lactone; pyranoindolizinoquinoline; quinoline alkaloid; tertiary alcohol | antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; genotoxin; plant metabolite |
3-hydroxy-quinazoline-2,4-dione | 3-hydroxy-quinazoline-2,4-dione: structure in first source | ||
2-(4-chlorophenyl)-3-methyl-N-(2-thiazolyl)butanamide | acetamides | ||
pecilocin | pecilocin: fungicidal antibiotic produced by Paecilomyces varioti Bainier var. antibioticus; structure | N-acylpyrrolidine | |
gw9508 | GW9508: structure in first source | aromatic amine | |
sch 725680 | Sch 725680: an aazaphilone from Aspergillus sp.; structure in first source | ||
pinophilin b | pinophilin B: from cultures of a fungus (Penicillium pinophilum Hedgcok) derived from a seaweed; structure in first source | ||
4-(((r)-1-(benzo(b)thiophene-3-carbonyl)-2-methyl-azetidine-2-carbonyl)-(3-chloro-benzyl)-amino)-butyric acid | 4-(((R)-1-(benzo(b)thiophene-3-carbonyl)-2-methyl-azetidine-2-carbonyl)-(3-chloro-benzyl)-amino)-butyric acid: structure in first source |